28779137|t|Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage.
28779137|a|The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD+) has neuroprotective effects, suggesting its potential use for treating epileptogenesis. Here we evaluated the effects of NAD+ on epileptogenesis and the mechanisms underlying these effects. In pilocarpine-induced status epilepticus (SE) model mice, NAD+ was injected three times within 24.5 h after SE. NAD+ intervention significantly reduced the incidence of spontaneous recurrent seizure (SRS) and abnormal electroencephalogram (EEG) activity, rescued contextual fear memory formation, reduced neuronal loss in the CA1 region of the hippocampus at SRS stage. Furthermore, exogenous supply of NAD+ distinctly reversed the seizure-induced depletion of endogenous NAD+, reduced neuronal apoptosis in the CA1 region of the hippocampus, and reversed the augmented Acp53/p53 ratio at the early stage of epileptogenesis. Our findings demonstrated that early-stage intervention with NAD+ prevents epileptogenesis in pilocarpine-induced SE mice by suppressing neuronal apoptosis.
28779137	0	33	Nicotinamide adenine dinucleotide	Chemical	MESH:D009243
28779137	252	285	nicotinamide adenine dinucleotide	Chemical	MESH:D009243
28779137	287	291	NAD+	Chemical	MESH:D009243
28779137	414	418	NAD+	Chemical	MESH:D009243
28779137	486	497	pilocarpine	Chemical	MESH:D010862
28779137	506	524	status epilepticus	Disease	MESH:D013226
28779137	526	528	SE	Disease	MESH:D013226
28779137	536	540	mice	Species	10090
28779137	542	546	NAD+	Chemical	MESH:D009243
28779137	592	594	SE	Disease	MESH:D013226
28779137	596	600	NAD+	Chemical	MESH:D009243
28779137	665	682	recurrent seizure	Disease	MESH:D012008
28779137	684	687	SRS	Disease	OMIM:614389
28779137	789	802	neuronal loss	Disease	MESH:D009410
28779137	843	846	SRS	Disease	OMIM:614389
28779137	887	891	NAD+	Chemical	MESH:D009243
28779137	916	923	seizure	Disease	MESH:D012640
28779137	956	960	NAD+	Chemical	MESH:D009243
28779137	970	988	neuronal apoptosis	Disease	MESH:D065703
28779137	1060	1063	p53	Gene	22060
28779137	1170	1174	NAD+	Chemical	MESH:D009243
28779137	1203	1214	pilocarpine	Chemical	MESH:D010862
28779137	1223	1225	SE	Disease	MESH:D013226
28779137	1226	1230	mice	Species	10090
28779137	1246	1264	neuronal apoptosis	Disease	MESH:D065703
28779137	Negative_Correlation	MESH:D009243	MESH:D010862
28779137	Positive_Correlation	MESH:D010862	MESH:D013226
28779137	Negative_Correlation	MESH:D009243	MESH:D012008
28779137	Negative_Correlation	MESH:D009243	MESH:D013226
28779137	Positive_Correlation	MESH:D009243	22060
28779137	Negative_Correlation	MESH:D009243	MESH:D012640
28779137	Negative_Correlation	MESH:D009243	OMIM:614389
28779137	Negative_Correlation	MESH:D009243	MESH:D065703
28779137	Negative_Correlation	MESH:D009243	MESH:D009410

